Tämä aineisto on vain terveydenhuollon ammattilaisten käyttöön,
sinut voidaan ohjata uudelle sivulle.


Oletko terveydenhuollon ammattilainen?
Tämä aineisto on vain terveydenhuollon ammattilaisten käyttöön. Sinut ohjataan nyt aloitus sivullemme.
The following content is restricted for consumers only.
You will be redirected.

Greg Behar

CEO of Nestlé Health Science S.A.

Date of birth: 1969
Nationality: Swiss
Languages: French, English, German, Spanish and Portuguese
Other: Married, 3 children

 

Career

  • 1 Oct 2014 - CEO Nestlé Health Science S.A.
  • 1 July 2014 - Designate CEO Nestlé Health Science
  • 2011 – 2014 - President & CEO Boehringer Ingelheim Pharmaceuticals Inc. (USA)
  • 2010 – 2011 - Corporate Vice President Region NECAR (North EU, Canada, Australasia), Boehringer-Ingelheim GmBH
  • 2009 – 2010 - Corporate Vice President of Cardiovascular and Metabolism Franchise, Boehringer-Ingelheim GmBH
  • 2002 – 2009 - Novartis Pharma (Switzerland, Region Europe and Spain)
  • 1995 – 2000 - Nestlé (Switzerland and Brazil)
  • 1993 – 1995 - R&D Project Manager, Bula & Fils (Switzerland)

Education

  • MBA, INSEAD, France
  • Master of Science in Mechanical Engineering and Manufacturing, EPFL, Switzerland
  • Bachelor of Science in Mechanical Engineering, University of California, UCLA, USA

Mandates

  • Board member, Accera, Inc. (USA)
  • Board member, Seres Therapeutics, Inc. (USA)
  • Board member, Axcella Health Inc. (USA)
  • Board member, Aimmune Therapeutics, Inc. (USA)
  • Chairman of the Board, Nutrition Science Partners
  • Member, Steering Committee of the Nestlé Institute of Health Sciences (Switzerland)